Role of IκB kinase in tumorigenesis | Future Oncology
Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition
CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells | Molecular Cancer | Full Text
Targeting the PI3K/AKT/mTOR/NF?B Axis in Ovarian Cancer
Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy | ACS Omega
Cyclin-Dependent Kinase 6 Phosphorylates NF-κB P65 at Serine 536 and Contributes to the Regulation of Inflammatory Gene Expression | PLOS ONE
Cancers | Free Full-Text | Targeting NF-κB Signaling for Multiple Myeloma
Pharmaceuticals | Free Full-Text | CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment
NF-κB and cell-cycle regulation: the cyclin connection - ScienceDirect
Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma - ScienceDirect
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
CDK4 and CDK6 kinases: From basic science to cancer therapy | Science
Cyclin-Dependent Kinase 6 Phosphorylates NF-kB P65 at Serine 536 and Contributes to the Regulation of Inflammatory Gene Expressi
Biomolecules | Free Full-Text | Phosphorylation of the Regulators, a Complex Facet of NF-κB Signaling in Cancer
CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells | Molecular Cancer | Full Text
A model of homeostatic cell-cycle control. (A) Inactivation of CDK4... | Download Scientific Diagram
Biomedicines | Free Full-Text | Targeting CDK4/6 for Anticancer Therapy
CDK6—a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation | Oncogene
Activation of the cyclin D2 and cdk6 genes through NF-κB is critical for cell-cycle progression induced by HTLV-I Tax | Oncogene
Cyclin-Dependent Kinase 6 Phosphorylates NF-kB P65 at Serine 536 and Contributes to the Regulation of Inflammatory Gene Expressi
Cyclin-Dependent Kinase 6 Is a Chromatin-Bound Cofactor for NF-κB-Dependent Gene Expression
Frontiers | CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
Therapy after cyclin‐dependent kinase inhibition in metastatic hormone receptor‐positive breast cancer: Resistance mechanisms and novel treatment strategies - Sharifi - 2020 - Cancer - Wiley Online Library
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells | Molecular Cancer | Full Text
Frontiers | T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses In Vivo
Inducible deletion of CDK4 and CDK6 – deciphering CDK4/6 inhibitor effects in the hematopoietic system | Haematologica
